Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning - Certain Enjoy Life brand bakery products recalled due to possible presence of pieces of plastic

Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/certain-enjoy-life-brand-bakery-products-recalled-due-possible-presence-pieces-plastic

OTTAWA, ON, June 30, 2022 /CNW/ - 

Affected products






Enjoy Life

Soft Baked Cookies -

170 g

8 53522 00018 4



Enjoy Life

Soft Baked Cookies ?
Chocolate Chip

170 g

8 53522 00019 1



Enjoy Life

Soft Baked Cookies ?
Double Chocolate

170 g

8 53522 00021 4


Enjoy Life

Chewy Bars ?
Chocolate Chip and

165 g

8 19597 01133 3


Enjoy Life

Breakfast Ovals ?
Chocolate Chip and

250 g

8 19597 01270 5



Enjoy Life

Breakfast Ovals ?
Berry Medley

250 g

8 19597 01271 2




The affected products are being recalled from the marketplace due to the possible presence of pieces of plastic.

The recalled products have been sold nationally and online.

What you should do

Learn more:


This recall was triggered by a recall in another country.

There have been no reported injuries associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)

These press releases may also interest you

at 21:05
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound...

at 20:30
On August 1, 2022, U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food and Drug Administration ("FDA"). Malignant glioma has...

at 20:10
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFN? in a...

at 20:05
GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator Professor Yi-Long Wu was invited to highlight key data in a press conferenceIn the final progression-free survival...

at 20:00
NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022....

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of...

News published on 1 july 2022 at 01:34 and distributed by: